|
Volumn 15, Issue 5, 2006, Pages 310-311
|
Montelukast is an effective monotherapy for mild asthma and for asthma with co-morbid allergic rhinitis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIINFLAMMATORY AGENT;
BRONCHODILATING AGENT;
FLUTICASONE;
LEUKOTRIENE RECEPTOR BLOCKING AGENT;
MONTELUKAST;
ADD ON THERAPY;
AGE DISTRIBUTION;
AIRWAY OBSTRUCTION;
ALLERGIC RHINITIS;
ASTHMA;
CLINICAL TRIAL;
COMORBIDITY;
COMPARATIVE STUDY;
DISEASE EXACERBATION;
DISEASE SEVERITY;
GENERAL PRACTITIONER;
HUMAN;
LETTER;
MONOTHERAPY;
OUTCOME ASSESSMENT;
POST HOC ANALYSIS;
PRACTICE GUIDELINE;
ACETATES;
ANTI-ASTHMATIC AGENTS;
ASTHMA;
CHILD, PRESCHOOL;
CLINICAL TRIALS;
CLINICAL TRIALS AS TOPIC;
HUMANS;
PRACTICE GUIDELINES;
PRACTICE GUIDELINES AS TOPIC;
QUINOLINES;
|
EID: 33749341805
PISSN: 14714418
EISSN: 14751534
Source Type: Journal
DOI: 10.1016/j.pcrj.2006.07.003 Document Type: Letter |
Times cited : (8)
|
References (7)
|